ADD-How does the FDA approval of NGS to test for MRD in multiple myeloma affect patients?

Description: In this week’s video, Dr. Durie discusses the two main types of minimal residual disease (MRD) tests for multiple myeloma – next-generation sequencing (NGS) and next-generation flow (NGF).

The BOTTOM LINE: The FDA approval of the NGS test for MRD is excellent news, but this testing is still not ready for use in day-to-day clinical practice.
Shared By : InternationalMyelomaFoundation
Posted on : 11/13/18
Added : 8 months ago
Category : Multiple Myeloma